Activating the GPR133 receptor with a small molecule can rebuild bone from within, offering a new direction for osteoporosis ...

Researchers have shown that a naturally occurring peptide (small protein) holds promise as a new therapeutic for osteoporosis and other disorders that feature bone loss, with distinct advantages over ...

Osteopenia causes reduced bone density without symptoms, driven by aging, hormones, and lifestyle factors. Early detection ...

Osteoblasts act in a group to make bone over the course of several months. However, how osteoblasts cooperate with each other in vivo is still unknown. Now, researchers at Osaka University established ...

In our bones, specialized cells called osteoblasts are responsible for building up bone substance. A team of researchers has now identified an enzyme that controls the activity of osteoblasts. An ...

Bone marrow is the spongy tissue located within the hollow center of bones, serving as the primary site for the continuous ...

Around 40% of adults worldwide are affected by osteopenia: a loss of bone mineral density. This condition is extremely common particularly in postmenopausal women and elderly adults. It’s estimated ...